These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 22096900)

  • 21. The molecular basis of HCV-mediated immune dysregulation.
    Eisen-Vandervelde AL; Yao ZQ; Hahn YS
    Clin Immunol; 2004 Apr; 111(1):16-21. PubMed ID: 15093547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hepatitis C virus subverts pattern recognition receptors-mediated control of adaptative immunity orchestrated by dendritic cells].
    Rodrigue-Gervais IG; Lamarre D
    Med Sci (Paris); 2010 Oct; 26(10):869-74. PubMed ID: 20929679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Chronic hepatitis C infection--mechanisms of virus "immune escape"].
    Nitkiewicz J
    Przegl Epidemiol; 2004; 58(3):423-33. PubMed ID: 15730006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection.
    Sugimoto K; Ikeda F; Stadanlick J; Nunes FA; Alter HJ; Chang KM
    Hepatology; 2003 Dec; 38(6):1437-48. PubMed ID: 14647055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasmacytoid dendritic cells initiate a complex chemokine and cytokine network and are a viable drug target in chronic HCV patients.
    Decalf J; Fernandes S; Longman R; Ahloulay M; Audat F; Lefrerre F; Rice CM; Pol S; Albert ML
    J Exp Med; 2007 Oct; 204(10):2423-37. PubMed ID: 17893202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virus infection regardless of enhanced expression of Toll-like receptors and retinoic acid inducible gene-I.
    Miyazaki M; Kanto T; Inoue M; Itose I; Miyatake H; Sakakibara M; Yakushijin T; Kakita N; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
    J Med Virol; 2008 Jun; 80(6):980-8. PubMed ID: 18428149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of viral and host factors in HCV persistence: which lesson for therapeutic and preventive strategies?
    Missale G; Cariani E; Ferrari C
    Dig Liver Dis; 2004 Nov; 36(11):703-11. PubMed ID: 15570998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adaptive immune responses in acute and chronic hepatitis C virus infection.
    Bowen DG; Walker CM
    Nature; 2005 Aug; 436(7053):946-52. PubMed ID: 16107834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathogenesis of chronic hepatitis C virus infection.
    Nelson DR; Lau JY
    Antivir Ther; 1998; 3(Suppl 3):25-35. PubMed ID: 10726053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Physiopathology of HCV infection].
    Zarski JP; Souvignet C
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B154-62. PubMed ID: 12180283
    [No Abstract]   [Full Text] [Related]  

  • 31. Hepatitis C virus E2 and CD81 interaction may be associated with altered trafficking of dendritic cells in chronic hepatitis C.
    Nattermann J; Zimmermann H; Iwan A; von Lilienfeld-Toal M; Leifeld L; Nischalke HD; Langhans B; Sauerbruch T; Spengler U
    Hepatology; 2006 Oct; 44(4):945-54. PubMed ID: 17006905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intrahepatic and circulating HLA class II-restricted, hepatitis C virus-specific T cells: functional characterization in patients with chronic hepatitis C.
    Penna A; Missale G; Lamonaca V; Pilli M; Mori C; Zanelli P; Cavalli A; Elia G; Ferrari C
    Hepatology; 2002 May; 35(5):1225-36. PubMed ID: 11981773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction between the hepatitis C virus and the immune system.
    Rehermann B
    Semin Liver Dis; 2000; 20(2):127-41. PubMed ID: 10946419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.
    López-Labrador FX; He XS; Berenguer M; Cheung RC; González-Candelas F; Wright TL; Greenberg HB
    J Med Virol; 2004 Apr; 72(4):575-85. PubMed ID: 14981760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immunomodulating effect of HCV during the development of chronic hepatitis C: toward new therapeutic approaches].
    Stoll-Keller F; Schvoerer E; Thumann C; Navas MC; Aubertin AM
    Bull Acad Natl Med; 2003; 187(6):1147-60; discussion 1160-1. PubMed ID: 14978874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impaired ability of interferon-alpha-primed dendritic cells to stimulate Th1-type CD4 T-cell response in chronic hepatitis C virus infection.
    Miyatake H; Kanto T; Inoue M; Sakakibara M; Kaimori A; Yakushijin T; Itose I; Miyazaki M; Kuzushita N; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
    J Viral Hepat; 2007 Jun; 14(6):404-12. PubMed ID: 17501761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence.
    Cerny A; Chisari FV
    Hepatology; 1999 Sep; 30(3):595-601. PubMed ID: 10462362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis C pathogenesis: mechanisms of viral clearance and liver injury.
    Rosen HR
    Liver Transpl; 2003 Nov; 9(11):S35-43. PubMed ID: 14586893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Chronic hepatitis C: virologic and immunologic aspects].
    Moriya K; Koike K
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):405-7. PubMed ID: 15359831
    [No Abstract]   [Full Text] [Related]  

  • 40. Fiber-modified recombinant adenoviral constructs encoding hepatitis C virus proteins induce potent HCV-specific T cell response.
    Thammanichanond D; Moneer S; Yotnda P; Aitken C; Earnest-Silveira L; Jackson D; Hellard M; McCluskey J; Torresi J; Bharadwaj M
    Clin Immunol; 2008 Sep; 128(3):329-39. PubMed ID: 18524682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.